Latest Advances

  • Condition: Recurrent Acute Myeloid Leukemia (AML)
  • Journal: American journal of hematology
  • Treatment Used: Three Novel Regimens
  • Number of Patients: 90
  • Published —
This study sought to improve the outcome of relapsed/refractory acute myeloid leukemia (AML), in a phase II trial of three novel regimens.
Showing 1-1 of 1